Stuart Beatty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stuart Beatty has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- E. Michael Murphy
Division of Pharmacy Practice and Science, The Ohio State University College of Pharmacy , Columbus, OH 43210
1 shared publication - Henry J Mann
Division of Pharmacy Practice and Science, The Ohio State University College of Pharmacy , Columbus, OH 43210
1 shared publication - Jennifer L. Bacci
University of Washington School of Pharmacy, Seattle, WA
1 shared publication - John G. Gums
College of Pharmacy, University of Florida , Gainesville, FL 32610
1 shared publication - Kyle Melin
School of Pharmacy, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico
1 shared publication Macarius M Donneyong
Division of Pharmacy Practice and Science, The Ohio State University College of Pharmacy , Columbus, OH 43210
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (10) , qxag252
Building on the 2025 national academies pharmacy workshop: ensuring access to community pharmacist care
Growing medication use, chronic disease burden, and primary care provider shortages have intensified the need for additional models of care delivery in the United States. Community pharmacists are uniquely positioned to help address these challenges through medication management, chronic disease management, and timely access to care. Evidence demonstrates that pharmacist services improve medication use and therapeutic outcomes while lowering overall health care costs. Despite these benefits, pharmacists remain underutilized as patient care providers, largely due to inconsistent reimbursement and business models that continue to prioritize product dispensing over patient care. Building on the 2025 National Academies of Sciences, Engineering, and Medicine workshop, Innovations in Pharmacy Training and Practice to Advance Patient Care, this paper examines existing and proposed state and federal payment policies and how their design influences implementation and scalability in community pharmacy practice. Recommendations include broad medical benefit reimbursement across payers, broad patient and service eligibility, and deference to state-defined scope of practice. Additional reforms are needed to address implementation barriers related to electronic health record access and credentialing. Together, these reforms can support sustainable, scalable community pharmacist-provided care and improve care access, quality, and affordability.
- 18 September 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (10) , qxag252
Open AccessBuilding on the 2025 national academies pharmacy workshop: ensuring access to community pharmacist care
Growing medication use, chronic disease burden, and primary care provider shortages have intensified the need for additional models of care delivery in the United States. Community pharmacists are uniquely positioned to help address these challenges through medication management, chronic disease management, and timely access to care. Evidence demonstrates that pharmacist services improve medication use and therapeutic outcomes while lowering overall health care costs. Despite these benefits, pharmacists remain underutilized as patient care providers, largely due to inconsistent reimbursement and business models that continue to prioritize product dispensing over patient care. Building on the 2025 National Academies of Sciences, Engineering, and Medicine workshop, Innovations in Pharmacy Training and Practice to Advance Patient Care, this paper examines existing and proposed state and federal payment policies and how their design influences implementation and scalability in community pharmacy practice. Recommendations include broad medical benefit reimbursement across payers, broad patient and service eligibility, and deference to state-defined scope of practice. Additional reforms are needed to address implementation barriers related to electronic health record access and credentialing. Together, these reforms can support sustainable, scalable community pharmacist-provided care and improve care access, quality, and affordability.
- Open Access
- 21 May 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (6) , qxag126
Pharmacist participation as providers in Ohio Medicaid: an analysis of claims, services, and billing patterns, 2021-2025
Introduction: States increasingly recognize pharmacists as medical-benefit providers, yet participation under Medicaid is not well documented. Methods: We conducted a retrospective descriptive analysis of pharmacist-submitted claims to the Ohio Department of Medicaid from January 2017 to January 2025. Claims included current procedural terminology/International Classification of Diseases-10 codes, paid/denied status, payment amounts, and place of service. Results: Pharmacists submitted 1424 claims before implementation and nearly 250 000 afterward, with more than 85% paid and $4.4 million reimbursed. Most claims occurred in team-based settings (Federally Qualified Health Centers [55%] and office practices [41%]) while community pharmacy billing was rare (0.19%). Common services included evaluation and management visits, preventive counseling, and continuous glucose monitoring; leading diagnoses were type 2 diabetes, hypertension, and nicotine dependence. Conclusion: Recognition of pharmacists as medical-benefit providers produced rapid participation at modest cost, primarily in integrated clinical settings. These findings suggest that streamlined referral processes and improved billing support may expand participation, particularly in community pharmacies.
- 21 May 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (6) , qxag126
Open AccessPharmacist participation as providers in Ohio Medicaid: an analysis of claims, services, and billing patterns, 2021-2025
Introduction: States increasingly recognize pharmacists as medical-benefit providers, yet participation under Medicaid is not well documented. Methods: We conducted a retrospective descriptive analysis of pharmacist-submitted claims to the Ohio Department of Medicaid from January 2017 to January 2025. Claims included current procedural terminology/International Classification of Diseases-10 codes, paid/denied status, payment amounts, and place of service. Results: Pharmacists submitted 1424 claims before implementation and nearly 250 000 afterward, with more than 85% paid and $4.4 million reimbursed. Most claims occurred in team-based settings (Federally Qualified Health Centers [55%] and office practices [41%]) while community pharmacy billing was rare (0.19%). Common services included evaluation and management visits, preventive counseling, and continuous glucose monitoring; leading diagnoses were type 2 diabetes, hypertension, and nicotine dependence. Conclusion: Recognition of pharmacists as medical-benefit providers produced rapid participation at modest cost, primarily in integrated clinical settings. These findings suggest that streamlined referral processes and improved billing support may expand participation, particularly in community pharmacies.